Quadrivalent influenza vaccine (MDCK cells)

Quadrivalent influenza vaccine produced in MDCK cells · Shanghai Institute Of Biological Products

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quadrivalent influenza vaccine (MDCK cells), covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above. [Phase 1]

See pricing